1. Home
  2. CRSP vs SIG Comparison

CRSP vs SIG Comparison

Compare CRSP & SIG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CRISPR Therapeutics AG

CRSP

CRISPR Therapeutics AG

HOLD

Current Price

$56.82

Market Cap

4.9B

Sector

Health Care

ML Signal

HOLD

Logo Signet Jewelers Limited

SIG

Signet Jewelers Limited

HOLD

Current Price

$93.44

Market Cap

4.0B

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRSP
SIG
Founded
2013
1950
Country
Switzerland
Bermuda
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Consumer Specialties
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
4.9B
4.0B
IPO Year
2016
1997

Fundamental Metrics

Financial Performance
Metric
CRSP
SIG
Price
$56.82
$93.44
Analyst Decision
Buy
Buy
Analyst Count
17
7
Target Price
$70.29
$111.14
AVG Volume (30 Days)
1.4M
938.0K
Earning Date
05-05-2026
06-02-2026
Dividend Yield
N/A
1.51%
EPS Growth
N/A
974.07
EPS
N/A
7.08
Revenue
$289,590,000.00
$6,247,100,000.00
Revenue This Year
$743.50
$1.36
Revenue Next Year
$163.21
$1.71
P/E Ratio
N/A
$13.11
Revenue Growth
9169.85
N/A
52 Week Low
$33.03
$52.14
52 Week High
$78.48
$110.20

Technical Indicators

Market Signals
Indicator
CRSP
SIG
Relative Strength Index (RSI) 65.66 57.33
Support Level $51.64 $89.54
Resistance Level $60.63 $95.10
Average True Range (ATR) 2.28 3.65
MACD 1.17 1.11
Stochastic Oscillator 94.14 93.89

Price Performance

Historical Comparison
CRSP
SIG

About CRSP CRISPR Therapeutics AG

Crispr Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for clustered regularly interspaced short palindromic repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. The company is focused on using this technology to treat genetically defined diseases. Crispr's first approved drug is Casgevy, which was developed in collaboration with Vertex Pharmaceuticals and targets sickle-cell disease and transfusion-dependent beta-thalassemia, which have high unmet medical needs. The company is advancing a variety of gene editing programs in immuno-oncology, cardiovascular, and a stem cell-derived therapy to treat Type 1 diabetes.

About SIG Signet Jewelers Limited

Signet Jewelers Ltd is a retailer of diamond jewelry. Its merchandise mix includes bridal, fashion, watches, and others. The bridal category includes engagement, wedding and anniversary purchases. Its segments are the North America segment, the International segment, and the Other segment. The North America segment contributes to the majority of the revenue. The North America segment generates revenue from Mall and Off-Mall & Outlet.

Share on Social Networks: